Organisation paid for research Program year 2022 Source: CMS Open Payments

Chesapeake Research Group LLC

Neither a doctor nor a teaching hospital

Research payments

$825,818

42 payments

Through program year 2022, Chesapeake Research Group LLC is reported as receiving $825,818 in research payments, across 42 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$491,422	34
2021	Research	$334,395	8

Breakdown

Who paid Research payments · program years 2021–2022

ACADIA Pharmaceuticals Inc $718,087 21 payments
Endo Pharmaceuticals Inc. $107,731 21 payments

Studies the money was for Research payments · program years 2021–2022

Acp-044-004 $372,488 11 payments
Acp-044-004 $345,599 10 payments
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis $79,692 11 payments
A Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis $24,564 9 payments
A Phase 1, Single Blind, Randomized, Placebo Controlled Dose Escalation Study to Assess the Safety, Effectiveness and Tolerability of a Single Treatment of EN3835 vs. Placebo for Recalcitrant Plantar Fasciitis (PFA) $3,475 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.